AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glivion M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Biovion Pharma Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glivion M 1mg/500mg Tablet SR

Diabex Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic agents. This dual-action medication treats type 2 diabetes in adults by managing blood glucose levels. Diabex Duo should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, it's a component of a comprehensive plan encompassing diet, exercise, and weight management as advised by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential. Alcohol consumption should be minimized due to its hypoglycemic potential. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your doctor before commencing treatment. Consult your physician before use during pregnancy or breastfeeding. Regular blood glucose monitoring, along with potential blood tests to assess blood cell counts and liver function, are recommended.

Uses of Glivion M 1mg/500mg Tablet SR

Managing Type 2 Diabetes

Major Benefits of Glivion M 1mg/500mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet whole; avoid chewing, crushing, or fracturing it. Consume Glivion M 1mg/500mg Tablet SR with a meal.

Common Side effects of Glivion M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glivion M 1mg/500mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or dividing it. Glivion M 1mg/500mg Extended-Release tablets should be taken with a meal.

How Glivion M 1mg/500mg Tablet SR works:

Glivion M 1mg/500mg Extended-Release tablets combine glimepiride and metformin, two agents that manage blood sugar. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Glivion M 1mg/500mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glivion M 1mg/500mg SR tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glivon M 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glivion M 1mg/500mg SR tablets; dosage modification may be necessary. Severe kidney disease contraindicates the use of Glivion M 1mg/500mg SR tablets. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Glivion M 1mg/500mg SR tablets to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician before administering. For patients exhibiting mild to moderate liver disease, initiate Glivion M 1mg/500mg SR treatment with a reduced starting dose; its use is contraindicated in cases of severe liver dysfunction.

What if you forget to take Glivion M 1mg/500mg Tablet SR :

Should you forget to take a Glivion M 1mg/500mg Tablet SR, ingest it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Glivion M 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Type of Treatment Diabetes Treatment

FAQs on Glivion M 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glivion M 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glivion M 1mg/500mg Tablet SR and seek immediate medical attention.
Glivion M 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Glivion M 1mg/500mg SR tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glivion M 1mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Glivion M 1mg/500mg SR tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glivion M 1mg/500mg SR tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glivion M 1mg/500mg Table...
78
MRP 90
13% off